APO Research
Talk to an analyst

APO RESEARCH · REPORT

Healthcare and Medical Simulation

Medical Simulation is the modern day methodology for training healthcare professionals through the use of advanced educational technology. Simply put, medical simulation is the experiential learning every healthcare professional will need, but cannot always engage in during real-life patient care. Medical simulation has also been called Healthcare Simulation, Simulation in Healthcare, Patient simulation, nursing simulation, surgical simulation and Clinical simulation.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Medical Simulation is the modern day methodology for training healthcare professionals through the use of advanced educational technology. Simply put, medical simulation is the experiential learning every healthcare professional will need, but cannot always engage in during real-life patient care. Medical simulation has also been called Healthcare Simulation, Simulation in Healthcare, Patient simulation, nursing simulation, surgical simulation and Clinical simulation.

Selected research

Market Outlook & Growth Opportunities

Global Healthcare and Medical Simulation Market Outlook and Growth Opportunities 2026

22 December 2025194 pages

Choose your research edition.

Industry ResearchHealthcare and Medical Simulation Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Healthcare and Medical Simulation Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Healthcare and Medical Simulation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Healthcare and Medical Simulation Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Healthcare and Medical Simulation Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Medical Simulation is the modern day methodology for training healthcare professionals through the use of advanced educational technology. Simply put, medical simulation is the experiential learning every healthcare professional will need, but cannot always engage in during real-life patient care. Medical simulation has also been called Healthcare Simulation, Simulation in Healthcare, Patient simulation, nursing simulation, surgical simulation and Clinical simulation.

North America is the largest market with about 35% market share. Europe is follower, accounting for about 29% market share.

The key players are Laerdal, CAE, 3D Systems, Ambu, Kyoto Kagaku, Limbs&Things, Simulaids, 3B Scientific Gmbh, Gaumard, Koken, Mentice, Surgical Science, Simulab, Sakamoto Model etc. Top 3 companies occupied about 40% market share.

Read the full market overview

This report provides an overview of the global Healthcare and Medical Simulation market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Healthcare and Medical Simulation and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Healthcare and Medical Simulation revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Healthcare and Medical Simulation market.

Healthcare and Medical Simulation Segment by Company

Laerdal

CAE

3D Systems

Ambu

Kyoto Kagaku

Limbs&Things

Simulaids

3B Scientific Gmbh

Gaumard

Koken

Mentice

Surgical Science

Simulab

Sakamoto Model

Healthcare and Medical Simulation Segment by Type

Software

Anatomical Models

Healthcare and Medical Simulation Segment by Application

Hospital

Medical College

Others

Healthcare and Medical Simulation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Healthcare and Medical Simulation status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Healthcare and Medical Simulation key companies, revenue, market share, and recent developments.

3. To split the Healthcare and Medical Simulation breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Healthcare and Medical Simulation market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Healthcare and Medical Simulation significant trends, drivers, influence factors in global and regions.

6. To analyze Healthcare and Medical Simulation competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Healthcare and Medical Simulation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Healthcare and Medical Simulation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Healthcare and Medical Simulation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Healthcare and Medical Simulation industry.

Chapter 3: Detailed analysis of Healthcare and Medical Simulation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Healthcare and Medical Simulation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Healthcare and Medical Simulation in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Healthcare and Medical Simulation Industry Trends Table 2. Healthcare and Medical Simulation Industry Drivers Table 3. Healthcare and Medical Simulation Industry Opportunities and Challenges Table 4. Healthcare and Medical Simulation Industry Restraints Table 5. Global Healthcare and Medical Simulation Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Healthcare and Medical Simulation Revenue Share by Company (2021-2026) Table 7. Global Healthcare and Medical Simulation Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Healthcare and Medical Simulation Key Company Manufacturing Base & Headquarters Table 9. Global Healthcare and Medical Simulation Company, Product Type & Application Table 10. Global Healthcare and Medical Simulation Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Healthcare and Medical Simulation by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Software Table 15. Significant Companies of Anatomical Models Table 16. Global Healthcare and Medical Simulation Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Healthcare and Medical Simulation Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Healthcare and Medical Simulation Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Healthcare and Medical Simulation Sales Value Share by Type (2021-2026) Table 20. Global Healthcare and Medical Simulation Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Medical College Table 23. Significant Companies of Others Table 24. Global Healthcare and Medical Simulation Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Healthcare and Medical Simulation Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Healthcare and Medical Simulation Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Healthcare and Medical Simulation Sales Value Share by Application (2021-2026) Table 28. Global Healthcare and Medical Simulation Sales Value Share by Application (2027-2032) Table 29. Global Healthcare and Medical Simulation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Healthcare and Medical Simulation Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Healthcare and Medical Simulation Sales Value Share by Region (2021-2026) Table 32. Global Healthcare and Medical Simulation Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Healthcare and Medical Simulation Sales Value Share by Region (2027-2032) Table 34. Global Healthcare and Medical Simulation Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Healthcare and Medical Simulation Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Healthcare and Medical Simulation Sales Value Market Share by Country (2021-2026) Table 37. Global Healthcare and Medical Simulation Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Healthcare and Medical Simulation Sales Value Market Share by Country (2027-2032) Table 39. Laerdal Company Information Table 40. Laerdal Business Overview Table 41. Laerdal Healthcare and Medical Simulation Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Laerdal Healthcare and Medical Simulation Product Portfolio Table 43. Laerdal Recent Development Table 44. CAE Company Information Table 45. CAE Business Overview Table 46. CAE Healthcare and Medical Simulation Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. CAE Healthcare and Medical Simulation Product Portfolio Table 48. CAE Recent Development Table 49. 3D Systems Company Information Table 50. 3D Systems Business Overview Table 51. 3D Systems Healthcare and Medical Simulation Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. 3D Systems Healthcare and Medical Simulation Product Portfolio Table 53. 3D Systems Recent Development Table 54. Ambu Company Information Table 55. Ambu Business Overview Table 56. Ambu Healthcare and Medical Simulation Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Ambu Healthcare and Medical Simulation Product Portfolio Table 58. Ambu Recent Development Table 59. Kyoto Kagaku Company Information Table 60. Kyoto Kagaku Business Overview Table 61. Kyoto Kagaku Healthcare and Medical Simulation Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Kyoto Kagaku Healthcare and Medical Simulation Product Portfolio Table 63. Kyoto Kagaku Recent Development Table 64. Limbs&Things Company Information Table 65. Limbs&Things Business Overview Table 66. Limbs&Things Healthcare and Medical Simulation Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Limbs&Things Healthcare and Medical Simulation Product Portfolio Table 68. Limbs&Things Recent Development Table 69. Simulaids Company Information Table 70. Simulaids Business Overview Table 71. Simulaids Healthcare and Medical Simulation Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Simulaids Healthcare and Medical Simulation Product Portfolio Table 73. Simulaids Recent Development Table 74. 3B Scientific Gmbh Company Information Table 75. 3B Scientific Gmbh Business Overview Table 76. 3B Scientific Gmbh Healthcare and Medical Simulation Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. 3B Scientific Gmbh Healthcare and Medical Simulation Product Portfolio Table 78. 3B Scientific Gmbh Recent Development Table 79. Gaumard Company Information Table 80. Gaumard Business Overview Table 81. Gaumard Healthcare and Medical Simulation Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Gaumard Healthcare and Medical Simulation Product Portfolio Table 83. Gaumard Recent Development Table 84. Koken Company Information Table 85. Koken Business Overview Table 86. Koken Healthcare and Medical Simulation Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Koken Healthcare and Medical Simulation Product Portfolio Table 88. Koken Recent Development Table 89. Mentice Company Information Table 90. Mentice Business Overview Table 91. Mentice Healthcare and Medical Simulation Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 92. Mentice Healthcare and Medical Simulation Product Portfolio Table 93. Mentice Recent Development Table 94. Surgical Science Company Information Table 95. Surgical Science Business Overview Table 96. Surgical Science Healthcare and Medical Simulation Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 97. Surgical Science Healthcare and Medical Simulation Product Portfolio Table 98. Surgical Science Recent Development Table 99. Simulab Company Information Table 100. Simulab Business Overview Table 101. Simulab Healthcare and Medical Simulation Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 102. Simulab Healthcare and Medical Simulation Product Portfolio Table 103. Simulab Recent Development Table 104. Sakamoto Model Company Information Table 105. Sakamoto Model Business Overview Table 106. Sakamoto Model Healthcare and Medical Simulation Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 107. Sakamoto Model Healthcare and Medical Simulation Product Portfolio Table 108. Sakamoto Model Recent Development Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Healthcare and Medical Simulation Product Image Figure 2. Global Healthcare and Medical Simulation Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Healthcare and Medical Simulation Market Size (2021-2032) & (US$ Million) Figure 4. Global Healthcare and Medical Simulation Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Software Image Figure 8. Anatomical Models Image Figure 9. Global Healthcare and Medical Simulation Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Healthcare and Medical Simulation Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Healthcare and Medical Simulation Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Medical College Image Figure 14. Others Image Figure 15. Global Healthcare and Medical Simulation Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Healthcare and Medical Simulation Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Healthcare and Medical Simulation Sales Value Share by Application (2021-2032) Figure 18. Global Healthcare and Medical Simulation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Healthcare and Medical Simulation Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Healthcare and Medical Simulation Sales Value (2021-2032) & (US$ Million) Figure 21. North America Healthcare and Medical Simulation Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Healthcare and Medical Simulation Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Healthcare and Medical Simulation Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Healthcare and Medical Simulation Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Healthcare and Medical Simulation Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Healthcare and Medical Simulation Sales Value (2021-2032) & (US$ Million) Figure 27. South America Healthcare and Medical Simulation Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Healthcare and Medical Simulation Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Healthcare and Medical Simulation Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Software
  • Anatomical Models
Applications
  • Hospital
  • Medical College
  • Others
Companies covered
  • Laerdal
  • CAE
  • 3D Systems
  • Ambu
  • Kyoto Kagaku
  • Limbs&Things
  • Simulaids
  • 3B Scientific Gmbh
  • Gaumard
  • Koken
  • Mentice
  • Surgical Science
  • Simulab
  • Sakamoto Model

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Healthcare and Medical Simulation Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Healthcare and Medical Simulation Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Healthcare and Medical Simulation Market Dynamics
  1. 2.1 Healthcare and Medical Simulation Industry Trends
  2. 2.2 Healthcare and Medical Simulation Industry Drivers
  3. 2.3 Healthcare and Medical Simulation Industry Opportunities and Challenges
  4. 2.4 Healthcare and Medical Simulation Industry Restraints
3 Healthcare and Medical Simulation Market by Company
  1. 3.1 Global Healthcare and Medical Simulation Company Revenue Ranking in 2025
  2. 3.2 Global Healthcare and Medical Simulation Revenue by Company (2021-2026)
  3. 3.3 Global Healthcare and Medical Simulation Company Ranking (2024-2026)
  4. 3.4 Global Healthcare and Medical Simulation Company Manufacturing Base and Headquarters
  5. 3.5 Global Healthcare and Medical Simulation Company Product Type and Application
  6. 3.6 Global Healthcare and Medical Simulation Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Healthcare and Medical Simulation Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Healthcare and Medical Simulation Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Healthcare and Medical Simulation Market by Type
  1. 4.1 Healthcare and Medical Simulation Type Introduction
  2. 4.1.1 Software
  3. 4.1.2 Anatomical Models
  4. 4.2 Global Healthcare and Medical Simulation Sales Value by Type
  5. 4.2.1 Global Healthcare and Medical Simulation Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Healthcare and Medical Simulation Sales Value by Type (2021-2032)
  7. 4.2.3 Global Healthcare and Medical Simulation Sales Value Share by Type (2021-2032)
5 Healthcare and Medical Simulation Market by Application
  1. 5.1 Healthcare and Medical Simulation Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Medical College
  4. 5.1.3 Others
  5. 5.2 Global Healthcare and Medical Simulation Sales Value by Application
  6. 5.2.1 Global Healthcare and Medical Simulation Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Healthcare and Medical Simulation Sales Value by Application (2021-2032)
  8. 5.2.3 Global Healthcare and Medical Simulation Sales Value Share by Application (2021-2032)
6 Healthcare and Medical Simulation Regional Value Analysis
  1. 6.1 Global Healthcare and Medical Simulation Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Healthcare and Medical Simulation Sales Value by Region (2021-2032)
  3. 6.2.1 Global Healthcare and Medical Simulation Sales Value by Region: 2021-2026
  4. 6.2.2 Global Healthcare and Medical Simulation Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Healthcare and Medical Simulation Sales Value (2021-2032)
  7. 6.3.2 North America Healthcare and Medical Simulation Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Healthcare and Medical Simulation Sales Value (2021-2032)
  10. 6.4.2 Europe Healthcare and Medical Simulation Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Healthcare and Medical Simulation Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Healthcare and Medical Simulation Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Healthcare and Medical Simulation Sales Value (2021-2032)
  16. 6.6.2 South America Healthcare and Medical Simulation Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Healthcare and Medical Simulation Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Healthcare and Medical Simulation Sales Value Share by Country, 2025 VS 2032
7 Healthcare and Medical Simulation Country-level Value Analysis
  1. 7.1 Global Healthcare and Medical Simulation Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Healthcare and Medical Simulation Sales Value by Country (2021-2032)
  3. 7.2.1 Global Healthcare and Medical Simulation Sales Value by Country (2021-2026)
  4. 7.2.2 Global Healthcare and Medical Simulation Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Healthcare and Medical Simulation Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Healthcare and Medical Simulation Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Healthcare and Medical Simulation Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Laerdal
  2. 8.1.1 Laerdal Company Information
  3. 8.1.2 Laerdal Business Overview
  4. 8.1.3 Laerdal Healthcare and Medical Simulation Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Laerdal Healthcare and Medical Simulation Product Portfolio
  6. 8.1.5 Laerdal Recent Developments
  7. 8.2 CAE
  8. 8.2.1 CAE Company Information
  9. 8.2.2 CAE Business Overview
  10. 8.2.3 CAE Healthcare and Medical Simulation Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CAE Healthcare and Medical Simulation Product Portfolio
  12. 8.2.5 CAE Recent Developments
  13. 8.3 3D Systems
  14. 8.3.1 3D Systems Company Information
  15. 8.3.2 3D Systems Business Overview
  16. 8.3.3 3D Systems Healthcare and Medical Simulation Revenue and Gross Margin (2021-2026)
  17. 8.3.4 3D Systems Healthcare and Medical Simulation Product Portfolio
  18. 8.3.5 3D Systems Recent Developments
  19. 8.4 Ambu
  20. 8.4.1 Ambu Company Information
  21. 8.4.2 Ambu Business Overview
  22. 8.4.3 Ambu Healthcare and Medical Simulation Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ambu Healthcare and Medical Simulation Product Portfolio
  24. 8.4.5 Ambu Recent Developments
  25. 8.5 Kyoto Kagaku
  26. 8.5.1 Kyoto Kagaku Company Information
  27. 8.5.2 Kyoto Kagaku Business Overview
  28. 8.5.3 Kyoto Kagaku Healthcare and Medical Simulation Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Kyoto Kagaku Healthcare and Medical Simulation Product Portfolio
  30. 8.5.5 Kyoto Kagaku Recent Developments
  31. 8.6 Limbs&Things
  32. 8.6.1 Limbs&Things Company Information
  33. 8.6.2 Limbs&Things Business Overview
  34. 8.6.3 Limbs&Things Healthcare and Medical Simulation Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Limbs&Things Healthcare and Medical Simulation Product Portfolio
  36. 8.6.5 Limbs&Things Recent Developments
  37. 8.7 Simulaids
  38. 8.7.1 Simulaids Company Information
  39. 8.7.2 Simulaids Business Overview
  40. 8.7.3 Simulaids Healthcare and Medical Simulation Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Simulaids Healthcare and Medical Simulation Product Portfolio
  42. 8.7.5 Simulaids Recent Developments
  43. 8.8 3B Scientific Gmbh
  44. 8.8.1 3B Scientific Gmbh Company Information
  45. 8.8.2 3B Scientific Gmbh Business Overview
  46. 8.8.3 3B Scientific Gmbh Healthcare and Medical Simulation Revenue and Gross Margin (2021-2026)
  47. 8.8.4 3B Scientific Gmbh Healthcare and Medical Simulation Product Portfolio
  48. 8.8.5 3B Scientific Gmbh Recent Developments
  49. 8.9 Gaumard
  50. 8.9.1 Gaumard Company Information
  51. 8.9.2 Gaumard Business Overview
  52. 8.9.3 Gaumard Healthcare and Medical Simulation Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Gaumard Healthcare and Medical Simulation Product Portfolio
  54. 8.9.5 Gaumard Recent Developments
  55. 8.10 Koken
  56. 8.10.1 Koken Company Information
  57. 8.10.2 Koken Business Overview
  58. 8.10.3 Koken Healthcare and Medical Simulation Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Koken Healthcare and Medical Simulation Product Portfolio
  60. 8.10.5 Koken Recent Developments
  61. 8.11 Mentice
  62. 8.11.1 Mentice Company Information
  63. 8.11.2 Mentice Business Overview
  64. 8.11.3 Mentice Healthcare and Medical Simulation Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Mentice Healthcare and Medical Simulation Product Portfolio
  66. 8.11.5 Mentice Recent Developments
  67. 8.12 Surgical Science
  68. 8.12.1 Surgical Science Company Information
  69. 8.12.2 Surgical Science Business Overview
  70. 8.12.3 Surgical Science Healthcare and Medical Simulation Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Surgical Science Healthcare and Medical Simulation Product Portfolio
  72. 8.12.5 Surgical Science Recent Developments
  73. 8.13 Simulab
  74. 8.13.1 Simulab Company Information
  75. 8.13.2 Simulab Business Overview
  76. 8.13.3 Simulab Healthcare and Medical Simulation Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Simulab Healthcare and Medical Simulation Product Portfolio
  78. 8.13.5 Simulab Recent Developments
  79. 8.14 Sakamoto Model
  80. 8.14.1 Sakamoto Model Company Information
  81. 8.14.2 Sakamoto Model Business Overview
  82. 8.14.3 Sakamoto Model Healthcare and Medical Simulation Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Sakamoto Model Healthcare and Medical Simulation Product Portfolio
  84. 8.14.5 Sakamoto Model Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst